BIB
$77.91
ProShares Ultra Nasdaq Biotechnology
ENDING SOONFirst 100 Only
Help Us Build Premium ETF Tools
4 quick questions • Get LIFETIME free access
Worth $2,400→ FREE
Explore sections
1 Month
+13.22%
YTD
+47.61%
1 Year
+47.61%
3 Year
+35.68%
Top 10 Holdings (37.3% of portfolio)
- United States of America9.29%
- Gilead Sciences Inc4.66%
- Amgen Inc4.53%
- Vertex Pharmaceuticals Inc4.01%
- Regeneron Pharmaceuticals In…4.00%
- Alnylam Pharmaceuticals Inc3.33%
- AstraZeneca PLC3.09%
- Insmed Inc1.63%
- ARGENX SE1.47%
- Biogen Inc1.27%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | United States of America | B 0 10/09/25 | Financials | 9.29% |
| 2 | Gilead Sciences Inc | GILD | Health Care | 4.66% |
| 3 | Amgen Inc | AMGN | Health Care | 4.53% |
| 4 | Vertex Pharmaceuticals Inc | VRTX | Health Care | 4.01% |
| 5 | Regeneron Pharmaceuticals Inc | REGN | Health Care | 4.00% |
| 6 | Alnylam Pharmaceuticals Inc | ALNY | Health Care | 3.33% |
| 7 | AstraZeneca PLC | AZN | Health Care | 3.09% |
| 8 | Insmed Inc | IM8N | Health Care | 1.63% |
| 9 | ARGENX SE | ARGX | Health Care | 1.47% |
| 10 | Biogen Inc | BIIB | Health Care | 1.27% |
Help Us Improve ETF Tools
Share your feedback and get early access to new features
Quick 2-minute survey→ FREE